Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Loper-Stop (General sale)
Active Ingredient:	Loperamide hydrochloride 2mg
Dosage Form:	Capsule
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Aspen Pharma Pty Limited, Dandenong South, Australia

*Product:*	Loper-Stop (Pharmacy only)
Active Ingredient:	Loperamide hydrochloride 2mg
Dosage Form:	Capsule
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Aspen Pharma Pty Limited, Dandenong South, Australia

*Product:*	Sunitinib Dr.Reddy’s
Active Ingredient:	Sunitinib malate 16.7mg equivalent to Sunitinib 12.5mg
Dosage Form:	Capsule
New Zealand Sponsor:	Dr Reddy's New Zealand Limited
Manufacturer:	Dr Reddy's Laboratories Limited, Visakhapatnam, India

*Product:*	Sunitinib Dr.Reddy’s
Active Ingredient:	Sunitinib malate 33.4mg equivalent to Sunitinib 25mg
Dosage Form:	Capsule
New Zealand Sponsor:	Dr Reddy's New Zealand Limited
Manufacturer:	Dr Reddy's Laboratories Limited, Visakhapatnam, India

*Product:*	Sunitinib Dr.Reddy’s
Active Ingredient:	Sunitinib malate 50.1mg equivalent to Sunitinib 37.5mg
Dosage Form:	Capsule
New Zealand Sponsor:	Dr Reddy's New Zealand Limited
Manufacturer:	Dr Reddy's Laboratories Limited, Visakhapatnam, India

*Product:*	Sunitinib Dr.Reddy’s
Active Ingredient:	Sunitinib malate 66.8mg equivalent to Sunitinib 50mg
Dosage Form:	Capsule
New Zealand Sponsor:	Dr Reddy's New Zealand Limited
Manufacturer:	Dr Reddy's Laboratories Limited, Visakhapatnam, India

Dated this 18th day of October 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule